Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Koop, Yvonne; Andres, Maria Sol; Couch, Liam S; Formisano, Luigi; Ciardiello, Fortunato; Pane, Fabrizio; Au, Lewis; Emmerich, Max; Plummer, Chris; Gulati, Geeta; Ramalingam, Sivatharshini; Cardinale, Daniela; Brezden-Masley, Christine; Iakobishvili, Zaza; Thavendiranathan, Paaladinesh; Santoro, Ciro; Bergler-Klein, Jutta; Keramida, Kalliopi; de Boer, Rudolf A; Maack, Christoph; Lutgens, Esther; Rassaf, Tienush; Fradley, Michael G; Moslehi, Javid; Yang, Eric H; De Keulenaer, Gilles; Ameri, Pietro; Bax, Jeroen; Neilan, Tomas G; Herrmann, Joerg; Mbakwem, Amam C; Mirabel, Mariana; Skouri, Hadi; Hirsch, Emilio; Cohen-Solal, Alain; Sverdlov, Aaron L; van der Meer, Peter; Asteggiano, Riccardo; Barac, Ana; Ky, Bonnie; Lenihan, Daniel; Dent, Susan; Seferovic, Petar; Coats, Andrew J S; Metra, Marco; Rosano, Giuseppe; Suter, Thomas; Lopez-Fernandez, Teresa; Lyon, Alexander R
(Oxford University Press, 2024-10)
The advent of immunological therapies has revolutionized the treatment of solid and haematological cancers over the last decade. Licensed therapies which activate the immune system to target cancer cells can be broadly ...